Riajay Bioplast Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1492.50%
- Profit Growth 195.56%
- Ebitda 430.91%
- Net Worth 680.89%
- Total Assets 31.38%
About Riajay Bioplast
Riajay Bioplast Private Limited (RBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 05 September 2018 (Six years and four months 30 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Sanghavi, Ria Sanghavi, and Jay Sanghavi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U25209MH2018PTC313555
-
Company No.
313555
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Sep 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Riajay Bioplast?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jay Sanghavi
|
Additional Director | 24-Jul-2020 | Current |
|
Hitesh Sanghavi
|
Director | 05-Sep-2018 | Current |
|
Ria Sanghavi
|
Director | 05-Sep-2018 | Current |
Financial Performance of Riajay Bioplast.
Riajay Bioplast Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1492.5% increase. The company also saw a substantial improvement in profitability, with a 195.56% increase in profit. The company's net worth Soared by an impressive increase of 680.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riajay Bioplast?
In 2022, Riajay Bioplast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Advance Biomaterial Company Private LimitedHitesh Sanghavi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Riajay Bioplast?
Unlock and access historical data on people associated with Riajay Bioplast, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riajay Bioplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riajay Bioplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.